LLRAPC Newsletter – August & September 2026(433 KB)
Date added: 30th Sep 2026
| Drug Name | Classification | Clinical Indication | Comments |
|---|---|---|---|
| AFICAMTEN (Myqorzo®) (NEW) | Red | for treating symptomatic obstructive hypertrophic cardiomyopathy |
In line with NICE TA1181 |
| ATOGEPANT (Aquipta®) (NEW) | Green | For treating acute migraine |
In line with NICE TA1172 Funding from 30th July 2026 |
| BECLOMETASONE Inhaler - CFC free (UPDATED) | Green | Asthma |
QVAR® brand recommended for adults. Soprobec® brand recommended only for children. Clenil Modulite® inhalers are being discontinued. Patients prescribed Clenil Modulite® 50 microgram or 100 microgram inhalers should be switched to the equivalent strength of Soprobec®, in line with the local SBAR and Medicines Supply Notification (MSN)
Soprobec® provides a like-for-like dose of beclometasone dipropionate; however, it does not include a dose counter.
|
| DEURUXOLITINIB (Leqselvi®) (NEW) | Red | for treating severe alopecia areata |
In line with TA1178
|
| DONIDALORSEN (Dawnzera®) (NEW) | Red | for preventing recurrent attacks of hereditary angioedema in people 12 years and over |
In line with NICE TA1183 Funding from 17th November 2026 |
| GLYCOPYRRONIUM BROMIDE CREAM (NEW) | Green | for treating severe primary axillary hyperhidrosis |
In line with NICE TA1175 Funding from 7th October 2026 |
| LIRAGLUTIDE (Diavic®) (UPDATED) | Green | Type 2 diabetes |
Diavic® is the preferred liraglutide formulation across LLR. Available only in line with NICE NG28 |
| SELADELPAR (Livdeli®) (NEW) | Red | for previously treated primary biliary cholangitis |
In line with NICE TA1171 Funding from 22nd September 2026 |
| TEPLIZUMAB (Tzield®) (NEW) | Red | for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes |
In line with NICE TA1176 Funding from 7th October 2026 |
Other Updates on this Website
Recent documents from LLR APC and TAS
Respiratory Prescribing Group Minutes July 2026(190 KB)
Date added: 28th Sep 2026
TAS Minutes 23rd June 2026(360 KB) - LMSG/LLR APC minutes
Date added: 23rd Sep 2026
TAS Minutes 25th August 2026(340 KB) - LMSG/LLR APC minutes
Date added: 23rd Sep 2026
LLR APC Meeting Minutes August 2026(388 KB) - LMSG/LLR APC minutes
Date added: 15th Sep 2026
SBAR LLR ICB Recommendations Clenil Discontinuation(615 KB)
Date added: 15th Sep 2026
About the Leicester, Leicestershire and Rutland Area Prescribing Committee
In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.
Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more